Reuters logo
BRIEF-Propeller Health announces FDA clearance of Propeller platform for use with GSK's Ellipta inhaler
November 7, 2016 / 11:43 AM / a year ago

BRIEF-Propeller Health announces FDA clearance of Propeller platform for use with GSK's Ellipta inhaler

Nov 7 (Reuters) - Propeller Health:

* Receives FDA clearance for Propeller platform in association with GSK’s Ellipta inhaler Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below